Where is Novartis headquartered?
Novartis's global corporate headquarters is in Basel, Switzerland, where the company has operated since its December 1996 formation on the banks of the Rhine. Basel hosts the Executive Committee, global corporate functions, the Novartis Institutes for BioMedical Research (NIBR), and multiple manufacturing and analytical entities. The US headquarters is at 1 Health Plaza, East Hanover, New Jersey — the hub of Novartis's largest commercial market (~$21B in 2024 US sales). Globally, Novartis operates in more than 140 countries with 30+ manufacturing sites across multiple continents, including the strategically critical Geneva Advanced Accelerator Applications (AAA) site for radioligand therapy.
- Global HQ
- Basel, Switzerland
- US HQ address
- 1 Health Plaza, East Hanover, NJ 07936
- Countries of operation
- 140+
- Manufacturing sites
- 30+ globally
- Employees
- ~75,267 (end-2025)
- US manufacturing commitment
- $23 billion announced in 2025 for new US drug manufacturing plants
Where does Novartis have offices and manufacturing sites?
Novartis's key offices and manufacturing locations span Switzerland, the United States, and major commercial markets across Europe, Asia-Pacific, and India.
- Basel, Switzerland· Global Headquarters
- Stein, Switzerland· Manufacturing (API)
- Schweizerhalle, Switzerland· Manufacturing (Chemical)
- Fribourg, Switzerland· Manufacturing
- Rotkreuz, Switzerland· Operations
- Geneva, Switzerland (AAA — RLT Center of Excellence)· R&D / Radioligand Therapy
- East Hanover, NJ, USA· US Headquarters
- Cambridge, MA, USA· R&D / Office
- Fort Worth, TX, USA· Manufacturing
- Holly Springs, NC, USA· Biologics Manufacturing
- London, UK· Office
- Munich, Germany· Office
- Paris, France· Office
- Hyderabad, India· Global Business Services (GBS)
- Beijing, China· Office
- Tokyo, Japan· Office
Sources:Novartis LocationsNovartis US Headquarters — SalesTools
Where is Novartis's headquarters?
Novartis's global corporate headquarters is in Basel, Switzerland — part of the world-class 'Pharma Triangle' life-sciences cluster alongside Roche and other global drug companies. The Basel campus hosts the Executive Committee, Group Finance, Legal, the Novartis Institutes for BioMedical Research (NIBR — one of the world's largest private biomedical research organizations), Novartis Pharma AG, and several manufacturing and analytical services entities including Novartis Pharma Schweizerhalle AG and Novartis Pharma Stein AG (active pharmaceutical ingredient manufacturing).
The US headquarters at 1 Health Plaza, East Hanover, NJ 07936 is home to Novartis Pharmaceuticals Corporation, the US commercial organization, medical affairs, and US regulatory affairs. Novartis is undertaking a multi-phase campus expansion at East Hanover to modernize the complex and accommodate future workforce growth. In 2025, the company also committed $23 billion to new US manufacturing investment, including construction of new drug manufacturing plants — a politically significant domestic investment program.
What other offices and manufacturing sites does Novartis operate?
Within Switzerland, major operational sites include Stein (active pharmaceutical ingredient manufacturing), Schweizerhalle (chemical manufacturing), Fribourg, Rotkreuz, and — most strategically — Geneva, which houses Advanced Accelerator Applications International SA (AAA), Novartis's radioligand therapy center of excellence. The Geneva/AAA site is critically important: it anchors Pluvicto (lutetium-177) manufacturing and the global scale-up of Novartis's RLT platform, which generated USD 1.9B in 2025 sales and is growing at +42% per year.
In the US, beyond East Hanover (NJ), Novartis has significant operations in Cambridge, MA (research offices), Fort Worth, TX (manufacturing), and Holly Springs, NC (biologics manufacturing). Internationally, Novartis operates a Global Business Services (GBS) center in Hyderabad, India, handling shared services, IT operations, and finance. Commercial offices cover all major EU markets (UK, Germany, France, Italy, Spain) and key Asia-Pacific markets (Japan, China, South Korea, Australia).
What Novartis's office footprint means for territory planning
For field sales and account-based marketing (ABM) targeting Novartis, geography matters enormously. The East Hanover, NJ campus is the primary US decision-making hub for Novartis Pharmaceuticals Corporation and the entire US commercial organization, making the New York Metro/New Jersey corridor the highest-priority US territory. The Cambridge, MA office hosts R&D and digital health functions, making it a secondary priority for vendors targeting clinical data, AI/ML, and research tools.
In Europe, Basel is the executive decision-making center — Swiss coverage is essential for any vendor seeking to engage the global ECN, procurement, or corporate IT. The Geneva/AAA site is the entry point for radioligand therapy-specific technology partnerships, process engineering tools, and radiopharmaceutical supply chain management. London and Munich are secondary EU commercial hubs. The Hyderabad GBS center is the entry point for shared services, IT operations, and back-office technology procurement — a high-value target for IT infrastructure, ERP, and finance tech vendors who can engage at scale.
As of June 2026.Sources:Novartis LocationsNovartis $23B US Manufacturing Commitment — BioPharma Dive
Novartis — frequently asked questions
